Download Files:
Carmofur
SKU
HY-B0182-100 mg
Category Reference compound
Tags Anti-infection;Cell Cycle/DNA Damage, Cancer, Nucleoside Antimetabolite/Analog;SARS-CoV;Virus Protease
$60 – $84
Products Details
Product Description
– Carmofur (HCFU), a derivative of 5-Fluorouracil, is an antineoplastic agent. Carmofur is an inhibitor of acid ceramidase with an IC50 of 79 nM for the rat enzyme. Carmofur inhibits the SARS-CoV-2 main protease (Mpro). Carmofur Inhibits SARS-CoV-2 in Vero E6 cell with an EC50 of  24.3  μM[1][2].
Web ID
– HY-B0182
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C11H16FN3O3
References
– [1]Realini N, et al. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Sci Rep. 2013;3:1035.|[2]Jin Z, et al. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020;27(6):529-532.
CAS Number
– 61422-45-5
Molecular Weight
– 257.26
Compound Purity
– 99.95
SMILES
– O=C(N(C(N1)=O)C=C(F)C1=O)NCCCCCC
Clinical Information
– Launched
Research Area
– Cancer
Solubility
– DMSO : ≥ 100 mg/mL|H2O : 0.67 mg/mL (ultrasonic)
Target
– Nucleoside Antimetabolite/Analog;SARS-CoV;Virus Protease
Pathway
– Anti-infection;Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.